The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 349:1916-1924 November 13, 2003 Number 20
NextNext

A Randomized Trial of Fetal Endoscopic Tracheal Occlusion for Severe Fetal Congenital Diaphragmatic Hernia
Michael R. Harrison, M.D., Roberta L. Keller, M.D., Samuel B. Hawgood, M.D., Joseph A. Kitterman, M.D., Per L. Sandberg, M.D., Diana L. Farmer, M.D., Hanmin Lee, M.D., Roy A. Filly, M.D., Jody A. Farrell, M.S.N., P.N.P., and Craig T. Albanese, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set

Commentary
-Perspective
 by Wenstrom, K. D.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
ABSTRACT

Background Experimental and clinical data suggest that fetal endoscopic tracheal occlusion to induce lung growth may improve the outcome of severe congenital diaphragmatic hernia. We performed a randomized, controlled trial comparing fetal tracheal occlusion with standard postnatal care.

Methods Women carrying fetuses that were between 22 and 27 weeks of gestation and that had severe, left-sided congenital diaphragmatic hernia (liver herniation and a lung-to-head ratio below 1.4), with no other detectable anomalies, were randomly assigned to fetal endoscopic tracheal occlusion or standard care. The primary outcome was survival at the age of 90 days; the secondary outcomes were measures of maternal and neonatal morbidity.

Results Of 28 women who met the entry criteria, 24 agreed to randomization. Enrollment was stopped after 24 patients had been enrolled because of the unexpectedly high survival rate with standard care and the conclusion of the data safety monitoring board that further recruitment would not result in significant differences between the groups. Eight of 11 fetuses (73 percent) in the tracheal-occlusion group and 10 of 13 (77 percent) in the group that received standard care survived to 90 days of age (P=1.00). The severity of the congenital diaphragmatic hernia at randomization, as measured by the lung-to-head ratio, was inversely related to survival in both groups. Premature rupture of the membranes and preterm delivery were more common in the group receiving the intervention than in the group receiving standard care (mean [±SD] gestational age at delivery, 30.8±2.0 weeks vs. 37.0±1.5 weeks; P<0.001). The rates of neonatal morbidity did not differ between the groups.

Conclusions Tracheal occlusion did not improve survival or morbidity rates in this cohort of fetuses with congenital diaphragmatic hernia.


Source Information

From the Fetal Treatment Center (M.R.H., S.B.H., J.A.K., P.L.S., D.L.F., H.L., R.A.F., J.A.F., C.T.A.), the Departments of Surgery (M.R.H., D.L.F., H.L., J.A.F., C.T.A.), Pediatrics (M.R.H., R.L.K., S.B.H., J.A.K., D.L.F., H.L., C.T.A.), Obstetrics, Gynecology and Reproductive Sciences (M.R.H., P.L.S., D.L.F., H.L., R.A.F., C.T.A.), and Radiology (R.A.F.), and the Cardiovascular Research Institute (R.L.K., J.A.K.), University of California, San Francisco, San Francisco.

Address reprint requests to Dr. Harrison at the University of California, San Francisco, Fetal Treatment Center, 513 Parnassus Ave., HSW-1601, San Francisco, CA 94143-0570, or at fetus{at}surgery.ucsf.edu.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.